In a 78-year-old woman with uncontrolled hypertension, which fixed-dose combination—Twynsta (telmisartan + amlodipine) or Tozam (losartan + amlodipine)—is more appropriate?

Twynsta (Telmisartan + Amlodipine) is the Superior Choice

For a 78-year-old woman with uncontrolled hypertension, Twynsta (telmisartan + amlodipine) is strongly preferred over Tozam (losartan + amlodipine) because telmisartan provides superior 24-hour blood pressure control, particularly in the critical last 6 hours of the dosing interval, and has demonstrated better cardiovascular outcomes in elderly, high-risk patients. 1, 2, 3

Rationale for Telmisartan Over Losartan

Superior Pharmacokinetic Profile

• Telmisartan 80 mg provides more sustained blood pressure reduction over the full 24-hour dosing interval compared to losartan 100 mg, which is critical for elderly patients who face higher cardiovascular risk during early morning hours when blood pressure typically surges. 3
• Telmisartan 80 mg was more effective than losartan 50 mg over the last 6 hours of the dosing interval and throughout the entire 24-hour period, demonstrating superior trough-to-peak ratios that translate to more consistent protection. 3
• Losartan 100 mg represents the maximum effective dose for hypertension; doses above this provide no additional blood pressure benefit, whereas telmisartan can be titrated to 80 mg with continued efficacy gains. 1

Evidence in High-Risk Elderly Populations

• The telmisartan/amlodipine combination is specifically recommended for elderly, high-risk hypertensive patients because it offers substantial and sustained 24-hour blood pressure lowering with excellent tolerability. 2
• In the ONTARGET study, telmisartan was equally effective to ramipril (an ACE inhibitor) but caused significantly less angioedema, making it safer for elderly patients who may have heightened sensitivity to adverse effects. 2
• The combination of telmisartan with amlodipine has been extensively studied in elderly patients, Type 2 diabetics, and those with systolic hypertension, demonstrating consistent efficacy across these high-risk subgroups common in a 78-year-old population. 4

Why the Amlodipine Component Matters

Guideline-Recommended Combination

• The European Society of Cardiology explicitly recommends RAS blocker (ARB) + dihydropyridine calcium channel blocker as preferred initial combination therapy for most patients with confirmed hypertension, including elderly individuals. 1
• For elderly patients ≥60 years, calcium channel blockers are specifically recommended as first-line therapy, and when combined with an ARB, provide complementary vasodilation and renin-angiotensin system blockade. 1

Metabolic Neutrality

• Both telmisartan and amlodipine are metabolically neutral, making them preferable for elderly patients who often have diabetes, metabolic syndrome, or multiple cardiovascular risk factors—conditions that worsen with thiazide diuretics. 5
• Unlike losartan/hydrochlorothiazide combinations, telmisartan/amlodipine does not cause hypokalemia, hyperglycemia, or hyperuricemia, which are particularly problematic in elderly patients. 6

Comparative Efficacy Data

Blood Pressure Reduction

• In patients with moderate-to-severe hypertension, telmisartan 80 mg + amlodipine 10 mg achieved blood pressure control (<140/90 mmHg) in 77% of patients and diastolic control (<90 mmHg) in 85%. 7
• Both telmisartan/amlodipine and losartan/amlodipine combinations produce similar office blood pressure reductions (approximately -25 mmHg systolic), but telmisartan provides more consistent 24-hour coverage. 6

Cardiovascular Outcomes

• The ACCOMPLISH trial demonstrated that ARB + amlodipine combinations were superior to ARB + hydrochlorothiazide in reducing cardiovascular events and death among high-risk patients, supporting the amlodipine-based strategy in both Twynsta and Tozam. 2

Practical Considerations for a 78-Year-Old

Dosing and Titration

• Start with telmisartan 40 mg + amlodipine 5 mg once daily, then titrate to telmisartan 80 mg + amlodipine 10 mg after 2-4 weeks if blood pressure remains ≥140/90 mmHg. 1, 7
• The maximum blood pressure reduction with telmisartan occurs at 40-80 mg/day, with most antihypertensive effect apparent within 2 weeks and maximal reduction at 4 weeks. 7, 3

Blood Pressure Targets

• For a 78-year-old in good functional health, target blood pressure is <140/90 mmHg minimum, with an optimal goal of 120-129 mmHg systolic if well tolerated. 1
• Reassess blood pressure within 2-4 weeks after initiating therapy, aiming to achieve target within 3 months. 1, 7

Monitoring

• Check serum potassium and creatinine 1-2 weeks after starting telmisartan, as ARBs can cause hyperkalemia, especially in elderly patients with reduced renal function. 1
• Monitor for orthostatic hypotension by checking blood pressure in both sitting and standing positions, as elderly patients have increased risk. 1

When to Add a Third Agent

• If blood pressure remains ≥140/90 mmHg after optimizing to telmisartan 80 mg + amlodipine 10 mg, add a thiazide-like diuretic (chlorthalidone 12.5 mg daily preferred) as the third agent to achieve guideline-recommended triple therapy. 1, 7
• Chlorthalidone 12.5 mg is the preferred starting dose in elderly patients to minimize hypokalemia risk, which increases 3-fold with doses >12.5 mg and eliminates cardiovascular protection when potassium drops below 3.5 mEq/L. 1

Critical Pitfalls to Avoid

• Do not use losartan doses above 100 mg daily for hypertension, as they provide no additional blood pressure benefit and are only studied in heart failure trials. 1
• Do not combine telmisartan with an ACE inhibitor (dual RAS blockade), as this increases hyperkalemia and acute kidney injury risk without cardiovascular benefit. 7
• Do not withhold treatment based on age alone; the 2024 ESC guidelines explicitly recommend continuing antihypertensive therapy lifelong beyond age 85 if well tolerated. 1
• Do not use beta-blockers as second or third-line agents unless compelling indications exist (heart failure, post-MI, angina), as they are less effective than calcium channel blockers for stroke prevention in elderly patients. 1

Lifestyle Adjuncts

• Sodium restriction to <2 g/day produces 5-10 mmHg systolic reduction and enhances the efficacy of both telmisartan and amlodipine. 1
• Weight management targeting BMI 20-25 kg/m² and regular aerobic exercise appropriate for functional capacity provide additive blood pressure reductions. 1
• Limit alcohol to <100 g/week (approximately 7 standard drinks). 1